<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01585922</url>
  </required_header>
  <id_info>
    <org_study_id>20120418BIRM</org_study_id>
    <nct_id>NCT01585922</nct_id>
  </id_info>
  <brief_title>Noninvasive Positive Pressure Ventilation in Moderate Acute Respiratory Distress Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Hospital</source>
  <brief_summary>
    <textblock>
      In order to identify the effect of noninvasive positive pressure ventilation (NPPV) on
      decreasing inflammatory response, improving the pathophysiological manifestation and reducing
      the morbidity and mortality in the moderate acute respiratory distress syndrome (ARDS)
      patients, the investigators conduct this clinical trial comparing NPPV with invasive
      mechanical ventilation in more than twenty ICUs in China.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>From the date of randomization to the date of discharge from ICU and hospital, or to the date of death of all cause, an expected average of 28 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>NPPV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use the NPPV to treat moderate ARDS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use invasive mechanical ventilation in treating the patients allocated to this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>noninvasive positive pressure ventilation (NPPV)</intervention_name>
    <description>Use NPPV to treat the ARDS patients,and we choose the NPPV ventilators in which the FiO2 can be fixed, for example: the BiPAP Vision or V60 of Phillip Respironics.</description>
    <arm_group_label>NPPV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>invasive mechanical ventilation</intervention_name>
    <description>Intubate and give invasive mechanical ventilation to the other group patients when they are allocated at once.</description>
    <arm_group_label>IMV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. acute onset

          2. a clinical presentation of respiratory distress

          3. arterial oxygen tension/inspired oxygen fraction (PaO2/FiO2) between 200 mmHg to 300
             mmHg. The arterial oxygen tension will be measured in fifteen minutes after NPPV (CPAP
             5 cmH2O) was used to the patients stably

          4. presence of bilateral pulmonary infiltrate on chest radiograph

          5. no evidence of left heart failure as assessed by echocardiography and/or a pulmonary
             artery wedge pressure( PAWP) &lt; 18 mmHg

        Exclusion Criteria:

          1. age &gt; 70 years or &lt; 18 years

          2. PaCO2 &gt; 50mmHg

          3. Glasgow Coma Scale (GCS)&lt; 11

          4. Upper airway/facial deformity or injury

          5. pneumothorax or pneumomediastinum

          6. unable to spontaneously clear secretions from their airway

          7. respiratory arrest

          8. severe ventricular arrhythmia or active myocardial ischemia

          9. severe organ dysfunction (including gastrointestinal hemorrhage, disseminated
             intravascular coagulation, hepatic and renal dysfunction, SOFA score &gt; 1)

         10. severe chronic lung diseases(COPD, Asthma or ILD, et al)

         11. end-stage patients who are expected to survive less than six months

         12. severe abdominal distension

         13. refuse to receive NPPV

         14. unable to cooperate with NPPV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bing Sun, MD</last_name>
    <phone>86-10-85231543</phone>
    <email>ards@vip.163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Institute of Respiratory Medicine, Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bing Sun, MD</last_name>
      <phone>86-10-85231543</phone>
      <email>ards@vip.163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2012</study_first_submitted>
  <study_first_submitted_qc>April 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2012</study_first_posted>
  <last_update_submitted>September 10, 2012</last_update_submitted>
  <last_update_submitted_qc>September 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Hospital</investigator_affiliation>
    <investigator_full_name>Chen Wang</investigator_full_name>
    <investigator_title>Vice President</investigator_title>
  </responsible_party>
  <keyword>noninvasive positive pressure ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

